Literature DB >> 8881770

Differential effects of osteopontin on the cytotoxic activity of macrophages from young and old mice.

E E Rollo1, D T Denhardt.   

Abstract

Osteopontin (OPN) is a secreted phosphoprotein found in body fluids (e.g. plasma, urine, milk) and in mineralized tissues. Its expression is increased in many transformed cells and in normal cells exposed to various cytokines. When stimulated with the inflammatory mediators lipopolysaccharide and interferon-gamma, mouse macrophages secrete nitric oxide (NO) as a cytotoxic agent effective against microbial invaders and tumour cells. This report documents (1) that thioglycollate-elicited peritoneal macrophages, activated with the inflammatory mediators, produced less NO and exhibited reduced cytotoxicity towards target cells when they were obtained from old animals than when they were obtained from young animals; and (2) that OPN was able to inhibit both the induced NO synthesis and cytotoxicity, but more effectively in macrophages from the young animals than those from the old animals. This may be due to the observed higher level of OPN expression in macrophages from old animals.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8881770      PMCID: PMC1456637          DOI: 10.1046/j.1365-2567.1996.d01-691.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  28 in total

1.  Cell proliferation and cytokine production by CD4+ cells from old mice.

Authors:  M V Hobbs; D N Ernst; B E Torbett; A L Glasebrook; M A Rehse; D N McQuitty; M L Thoman; K Bottomly; A L Rothermel; D J Noonan
Journal:  J Cell Biochem       Date:  1991-08       Impact factor: 4.429

Review 2.  Oxidants, antioxidants, and the degenerative diseases of aging.

Authors:  B N Ames; M K Shigenaga; T M Hagen
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

3.  Patterns of cytokine gene expression by CD4+ T cells from young and old mice.

Authors:  M V Hobbs; W O Weigle; D J Noonan; B E Torbett; R J McEvilly; R J Koch; G J Cardenas; D N Ernst
Journal:  J Immunol       Date:  1993-04-15       Impact factor: 5.422

4.  Reduced malignancy of ras-transformed NIH 3T3 cells expressing antisense osteopontin RNA.

Authors:  E I Behrend; A M Craig; S M Wilson; D T Denhardt; A F Chambers
Journal:  Cancer Res       Date:  1994-02-01       Impact factor: 12.701

5.  Oxidation of nitric oxide in aqueous solution to nitrite but not nitrate: comparison with enzymatically formed nitric oxide from L-arginine.

Authors:  L J Ignarro; J M Fukuto; J M Griscavage; N E Rogers; R E Byrns
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

6.  Memory T lymphocyte hyporesponsiveness to non-cognate stimuli: a key factor in age-related immunodeficiency.

Authors:  K Flurkey; M Stadecker; R A Miller
Journal:  Eur J Immunol       Date:  1992-04       Impact factor: 5.532

Review 7.  Osteopontin: a protein with diverse functions.

Authors:  D T Denhardt; X Guo
Journal:  FASEB J       Date:  1993-12       Impact factor: 5.191

8.  Heterogeneity of osteopontin expression among nephrons in mouse kidneys and enhanced expression in sclerotic glomeruli.

Authors:  C A Lopez; J R Hoyer; P D Wilson; P Waterhouse; D T Denhardt
Journal:  Lab Invest       Date:  1993-09       Impact factor: 5.662

9.  Expression of the nitric oxide synthase gene in mouse macrophages activated for tumor cell killing. Molecular basis for the synergy between interferon-gamma and lipopolysaccharide.

Authors:  R B Lorsbach; W J Murphy; C J Lowenstein; S H Snyder; S W Russell
Journal:  J Biol Chem       Date:  1993-01-25       Impact factor: 5.157

10.  Induction of osteopontin mRNA expression during activation of murine NK cells.

Authors:  S B Pollack; P A Linnemeyer; S Gill
Journal:  J Leukoc Biol       Date:  1994-03       Impact factor: 4.962

View more
  9 in total

1.  Polymorphism in Osteopontin Gene (SPP1) Is Associated with Asthma and Related Phenotypes in a Puerto Rican Population.

Authors:  Mehrdad Arjomandi; Josh M Galanter; Shweta Choudhry; Celeste Eng; Donglei Hu; Kenneth Beckman; Rocío Chapela; José R Rodríguez-Santana; William Rodríguez-Cintrón; Jean Ford; Pedro C Avila; Esteban G Burchard
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2011-12       Impact factor: 1.349

Review 2.  Osteopontin: an effector and an effect of tumor metastasis.

Authors:  L A Shevde; S Das; D W Clark; R S Samant
Journal:  Curr Mol Med       Date:  2010-02       Impact factor: 2.222

3.  Osteopontin binding to lipopolysaccharide lowers tumor necrosis factor-α and prevents early alcohol-induced liver injury in mice.

Authors:  Xiaodong Ge; Tung-Ming Leung; Elena Arriazu; Yongke Lu; Raquel Urtasun; Brian Christensen; Maria Isabel Fiel; Satoshi Mochida; Esben S Sørensen; Natalia Nieto
Journal:  Hepatology       Date:  2014-03-01       Impact factor: 17.425

Review 4.  Immunosenescence and organ transplantation.

Authors:  Timm Heinbokel; Abdallah Elkhal; Guangxiang Liu; Karoline Edtinger; Stefan G Tullius
Journal:  Transplant Rev (Orlando)       Date:  2013-04-30       Impact factor: 3.943

5.  Osteopontin is not crucial to protective immunity during murine tuberculosis.

Authors:  Gerritje J W van der Windt; Catharina W Wieland; Willem J Wiersinga; Sandrine Florquin; Tom van der Poll
Journal:  Immunology       Date:  2009-02-17       Impact factor: 7.397

6.  Secreted osteopontin is highly polymerized in human airways and fragmented in asthmatic airway secretions.

Authors:  Mehrdad Arjomandi; Jessica Frelinger; Aneesh Donde; Hofer Wong; Amritha Yellamilli; Wilfred Raymond
Journal:  PLoS One       Date:  2011-10-21       Impact factor: 3.240

Review 7.  The Effect of Osteopontin on Microglia.

Authors:  Huan Yu; Xiaohong Liu; Yisheng Zhong
Journal:  Biomed Res Int       Date:  2017-06-18       Impact factor: 3.411

Review 8.  Danger signals in the initiation of the inflammatory response after myocardial infarction.

Authors:  J J de Haan; M B Smeets; G Pasterkamp; F Arslan
Journal:  Mediators Inflamm       Date:  2013-11-30       Impact factor: 4.711

9.  Osteopontin ablation ameliorates muscular dystrophy by shifting macrophages to a pro-regenerative phenotype.

Authors:  Joana Capote; Irina Kramerova; Leonel Martinez; Sylvia Vetrone; Elisabeth R Barton; H Lee Sweeney; M Carrie Miceli; Melissa J Spencer
Journal:  J Cell Biol       Date:  2016-04-18       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.